Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anticancer agents and apoptosis]

M Fukuda, N Saijo

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |February 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    The bcl-2 protein inhibits apoptosis, a key process in programmed cell death, making cancer cells resistant to certain chemotherapy drugs. This suggests bcl-2 can modulate anti-cancer agent effectiveness.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans.

    The Journal of biological chemistry·1992
    Same author

    Shortening of N1 and P3 latencies in event-related potentials observed coincidentally with clinical improvement during nootropic medication in a demented patient: specific effect of nicergoline.

    The Japanese journal of psychiatry and neurology·1992
    Same author

    Chediak-Higashi lymphoblastoid cell lines: granule characteristics and expression of lysosome-associated membrane proteins.

    Clinical immunology and immunopathology·1992
    Same author

    Distributions of the Nd and P300 in a normal sample.

    International journal of psychophysiology : official journal of the International Organization of Psychophysiology·1992
    Same author

    [Short-latency somatosensory evoked potentials in patients with hypertensive intracerebral hemorrhage: clinical availability of N20 component].

    No shinkei geka. Neurological surgery·1992
    Same author

    [Clinical characteristic of elderly patients with insulin-dependent diabetes mellitus].

    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics·1992
    Same journal

    [A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [Recent Advances in the Treatment of HER2-Altered Solid Tumors].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    Same journal

    [BRAF-Mutant Solid Tumor].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026
    See all related articles

    Area of Science:

    • Cell Biology
    • Molecular Oncology
    • Immunology

    Context:

    • Programmed cell death (apoptosis) is a critical biological process studied in various fields, including immunology, developmental biology, and oncology.
    • Recent advancements in understanding apoptosis have positioned it as a mainstream area of biological research.

    Purpose:

    • To investigate whether the anti-apoptotic protein bcl-2 can inhibit apoptosis induced by anti-cancer agents.
    • To establish and utilize a bcl-2-transfected human small cell lung cancer cell line (SBC-3/Bcl-2) for experimental purposes.

    Summary:

    • The bcl-2-transfected cell line, SBC-3/Bcl-2, exhibited increased resistance to specific anti-cancer drugs like ADM, CPT-11, and MMC compared to the parental SBC-3 line.
    • DNA fragmentation, a hallmark of apoptosis, was observed in SBC-3 cells treated with CPT-11 or MMC, but not in SBC-3/Bcl-2 cells at equivalent drug concentrations.

    Related Experiment Videos

  • Sensitivity to other agents, including CDDP, VP-16, ACNU, MTX, and Taxol, remained unchanged between the parental and transfected cell lines.

    • Impact:

    • These findings demonstrate that bcl-2 can modulate the cytotoxicity of certain anti-cancer agents by interfering with the apoptotic cell death pathway.
    • The study suggests the existence of distinct apoptotic pathways, some of which are sensitive to bcl-2, while others are independent of its influence.